|
ACBD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.055200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.196780E-01 |
| Normal-vs-Stage2 |
4.603800E-01 |
| Normal-vs-Stage3 |
5.184400E-01 |
| Normal-vs-Stage4 |
2.921200E-01 |
| Stage1-vs-Stage2 |
9.316200E-01 |
| Stage1-vs-Stage3 |
6.791700E-02 |
| Stage1-vs-Stage4 |
2.202200E-02 |
| Stage2-vs-Stage3 |
2.722200E-01 |
| Stage2-vs-Stage4 |
1.713980E-01 |
| Stage3-vs-Stage4 |
7.528800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.466000E-01 |
| Normal-vs-AfricanAmerican |
6.592400E-02 |
| Normal-vs-Asian |
2.163000E-01 |
| Caucasian-vs-AfricanAmerican |
1.187510E-02 |
| Caucasian-vs-Asian |
2.442600E-01 |
| AfricanAmerican-vs-Asian |
2.024300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.573000E-01 |
| Normal-vs-Female |
2.685000E-01 |
| Male-vs-Female |
2.508800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.644600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.980200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.778400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.866800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.619600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.977000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.915800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.079200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.076600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.466400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.740200E-02 |
| Normal-vs-Grade 2 |
1.215050E-01 |
| Normal-vs-Grade 3 |
8.217600E-01 |
| Normal-vs-Grade 4 |
2.308800E-01 |
| Grade 1-vs-Grade 2 |
6.355000E-01 |
| Grade 1-vs-Grade 3 |
2.207800E-01 |
| Grade 1-vs-Grade 4 |
9.719700E-02 |
| Grade 2-vs-Grade 3 |
7.215500E-02 |
| Grade 2-vs-Grade 4 |
2.773600E-02 |
| Grade 3-vs-Grade 4 |
2.925200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.779000E-03 |
| Normal-vs-ccB subtype |
8.858000E-01 |
| ccA subtype-vs-ccB subtype |
9.362400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.035000E-01 |
| Normal-vs-N1 |
8.208400E-01 |
| N0-vs-N1 |
9.206800E-01 |
|
|
